Table 2. In Vitro Safety Assessment and Plasma Stability of Tested Compounds 14–16 and 21–24.
| Caco-2 cell permeability (50 μM) | rat plasma stability | human plasma stability | |
|---|---|---|---|
| compound | Papp (cm/s) | % remaining after 8 h | |
| 14 | 5.7 × 10–6 | 55 | 100 |
| 15 | 1.9 × 10–6 | 99 | 100 |
| 16 | 1.2 × 10–6 | 43 | 94 |
| 21 | 1.0 × 10–4 | 88 | 99 |
| 22 | 1.2 × 10–5 | 57 | 98 |
| 23 | 3.1 × 10–6 | 32 | 100 |
| 24 | 1.3 × 10–6 | 38 | 100 |